12064-018 : Nucala 100 mg/ml Subcutaneous Injection, Powder, for Solution


NDC: 12064-018
Labeler: Glaxosmithkline Manufacturing Spa
Product Type: Human Prescription Drug
Drug Name:  Nucala
Dosage Form: Subcutaneous Injection, Powder, for Solution
Application #: BLA125526
Rev. Date: 


NDC Package Codes:

  • 12064-018-00: 1 VIAL IN 1 CARTON (12064‑018‑00) > 1 ML IN 1 VIAL
  • 12064-018-01: 1 VIAL IN 1 CARTON (12064‑018‑01) > 1 ML IN 1 VIAL

Active Ingredients:

  • Mepolizumab

Dosage Strength:

  • 100 mg/mL

Pharmaceutical Classes:

  • Interleukin-5 Antagonist [EPC]
  • Interleukin-5 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0173-0881 Nucala 100 mg/ml Subcutaneous Injection, Powder, for Solution by Glaxosmithkline LLC
  • 0173-0892 Nucala 100 mg/ml Subcutaneous Injection, Solution by Glaxosmithkline LLC
  • 0173-0904 Nucala 40 mg/.4ml Subcutaneous Injection, Solution by Glaxosmithkline LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 12064-018 QR Code

< Prev: 12064-017Next: 12090-0015 >

Related Discussions:

can mepolizumab be a cause for hypercalcemia?
I have a patient on a trial with it, and now she has hypercalcemia. Could this be due to the med or do I have to investi... 1 reply




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.